Marker Therapeutics, Inc. (MRKR)
1.45
-0.05
(-3.33%)
USD |
NASDAQ |
Feb 20, 16:00
1.46
+0.01
(+0.69%)
After-Hours: 20:00
Marker Therapeutics SG&A Expense (Quarterly) : 1.024M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 23.05M |
| Viridian Therapeutics, Inc. | 24.32M |
| ACADIA Pharmaceuticals, Inc. | 133.40M |
| Kiniksa Pharmaceuticals International Plc | 49.10M |
| Neurocrine Biosciences, Inc. | 301.80M |